Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2017

Pharma News, 2017

New clinical data support durvalumab FDA approval bid
New clinical data support durvalumab FDA approval bid
Anglo-Swedish drugmaker AstraZeneca (LSE.
Pharma industry to reach $55 billion in three years, says ASSOCHAM-IITTM study
Pharma industry to reach $55 billion in three years, says ASSOCHAM-IITTM study
Indian pharmaceuticals market is expected to touch US $55 billion by 2020 from the current level of US $36.
Hope for new treatment for Huntington's disease
Hope for new treatment for Huntington's disease
Researchers working at Karolinska Institutet in Sweden and University of Southern Denmark have managed to produce short synthetic DNA analogues – oligonucleotides – that bind directly to the gene ...
Adding vitamin B3 to your water could boost eye health and help to prevent glaucoma, study finds
Adding vitamin B3 to your water could boost eye health and help to prevent glaucoma, study finds
Adding vitamin B3 to water may protect you against glaucoma, a study reveals.
The secret to prevent Parkinson's disease is in our genes!
The secret to prevent Parkinson's disease is in our genes!
New Delhi.
Ozanimod shows promise in Phase III MS trial, beating Avonex
Ozanimod shows promise in Phase III MS trial, beating Avonex
The Phase III SUNBEAM trial, evaluating the efficacy and safety of ozanimod, an investigational oral, selective S1P 1 and 5 receptor modulator, in patients with relapsing multiple sclerosis (RMS&#...
Pivotal Phase III trial of HIV MAb ibalizumab successful
Pivotal Phase III trial of HIV MAb ibalizumab successful
New data presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2017 showed that patients with multidrug resistant (MDR) HIV-1 infection experienced a mean inc...
Vitamin D supplements may prevent millions of winter infections
Vitamin D supplements may prevent millions of winter infections
If everyone took vitamin D supplements, more than 3 million fewer people in the UK would have respiratory infections like colds or flu every year.
U.S. experts soften on DNA editing of human eggs, sperm, embryos
U.S. experts soften on DNA editing of human eggs, sperm, embryos
Powerful gene editing tools may one day be used on human embryos, eggs and sperm to remove genes that cause inherited diseases, according to a report by U.
New malaria vaccine effective in clinical trial
New malaria vaccine effective in clinical trial
University of Tübingen researchers in collaboration with the biotech company Sanaria Inc.
Merck & Co’s HIV drug meets Phase III trial endpoint
Merck & Co’s HIV drug meets Phase III trial endpoint
US pharma major Merck & Co (NYSE.
U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Pegfilgrastim for Review
U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Pegfilgrastim for Review
HERTFORDSHIRE, England, PITTSBURGH and BENGALURU, India, Feb.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand